Large-scale testing (Phase 3)Study completedNCT05120297What this trial is testingEfficacy and Safety of AK101 in Subjects With PsoriasisWho this might be right forPsoriasis Vulgaris Akeso 452
Testing effectiveness (Phase 2)Study completedNCT01208090What this trial is testingACT-128800 in Patients With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Actelion 326
Large-scale testing (Phase 3)Study completedNCT02474082What this trial is testingStudy of Secukinumab Compared to Fumaderm® in Adults With Moderate to Severe Psoriasis.Who this might be right forPsoriasis Novartis Pharmaceuticals 202
Large-scale testing (Phase 3)Study completedNCT00111449What this trial is testingEvaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With PsoriasisWho this might be right forPsoriasis Amgen 600
Testing effectiveness (Phase 2)Ended earlyNCT02243787What this trial is testingSafety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Covagen 24
Large-scale testing (Phase 3)Study completedNCT06049810What this trial is testingIBI112 in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatmentWho this might be right forPsoriasis Innovent Biologics (Suzhou) Co. Ltd. 566
Large-scale testing (Phase 3)Study completedNCT01008995What this trial is testingThe Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With PsoriasisWho this might be right forPsoriasis Centocor, Inc. 322
Not applicableStudy completedNCT01202565What this trial is testingEffectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical PracticeWho this might be right forModerate to Severe Plaque Psoriasis AbbVie (prior sponsor, Abbott) 506
Testing effectiveness (Phase 2)Study completedNCT02933502What this trial is testingSafety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical ProductWho this might be right forScalp Psoriasis Sun Pharmaceutical Industries, Inc. 3
Early research (Phase 1)Looking for participantsNCT07024602What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque PsoriasisWho this might be right forPlaque Psoriasis Ascletis Pharma (China) Co., Limited 94
Large-scale testing (Phase 3)Study completedNCT03721172What this trial is testingApremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and EfficacyWho this might be right forPsoriasis Amgen 595
Testing effectiveness (Phase 2)Study completedNCT02173301What this trial is testingAssess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type PsoriasisWho this might be right forPsoriasis Dr. Reddy's Laboratories Limited 200
Post-approval studies (Phase 4)Study completedNCT00312026What this trial is testingEvaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or FeetWho this might be right forPsoriasis Genentech, Inc. 75
Testing effectiveness (Phase 2)Study completedNCT03832738What this trial is testingStudy to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque PsoriasisPsoriasisSkin Diseases Akros Pharma Inc. 152
Large-scale testing (Phase 3)Study completedNCT01406938What this trial is testingEfficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose RegimensWho this might be right forModerate to Severe Plaque-type Psoriasis Novartis Pharmaceuticals 967
Early research (Phase 1)Study completedNCT02534636What this trial is testingSafety Study of BMS-986165 in Healthy Subjects and to Treat PsoriasisWho this might be right forHealthy Subjects Bristol-Myers Squibb 140
Post-approval studies (Phase 4)Study completedNCT01722214What this trial is testingTrial on the Effect of Adalimumab on Vascular Inflammation in Patients With PsoriasisWho this might be right forPsoriasisVascular InflammationCoronary Atherosclerosis Innovaderm Research Inc. 107
Testing effectiveness (Phase 2)Study completedNCT04664153What this trial is testingStudy To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque PsoriasisWho this might be right forAtopic DermatitisPlaque Psoriasis Pfizer 104
Large-scale testing (Phase 3)Study completedNCT01597245What this trial is testingStudy in Participants With Moderate to Severe Psoriasis (UNCOVER-2)Who this might be right forPsoriasis Eli Lilly and Company 1,224
Not applicableStudy completedNCT05344482What this trial is testingEvaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Novartis Pharmaceuticals 277